Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1875 1
1947 1
1949 1
1950 1
1951 1
1952 2
1954 3
1956 2
1958 5
1959 4
1960 4
1961 4
1962 4
1963 2
1964 4
1965 4
1966 4
1968 6
1969 3
1970 3
1971 4
1972 9
1973 6
1974 10
1975 9
1976 8
1977 11
1978 8
1979 21
1980 17
1981 17
1982 10
1983 6
1984 6
1985 9
1986 12
1987 9
1988 15
1989 12
1990 9
1991 15
1992 10
1993 6
1994 9
1995 11
1996 12
1997 12
1998 7
1999 14
2000 7
2001 17
2002 15
2003 17
2004 11
2005 13
2006 10
2007 11
2008 14
2009 12
2010 4
2011 2
2012 1
2013 1
2014 3
2015 2
2016 2
2017 1
2019 1
2020 3
2021 1
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

513 results

Results by year

Filters applied: . Clear all
Page 1
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.
Pan Y, Han H, Hu H, Wang H, Song Y, Hao Y, Tong X, Patel AS, Misirlioglu S, Tang S, Huang HY, Geng K, Chen T, Karatza A, Sherman F, Labbe KE, Yang F, Chafitz A, Peng C, Guo C, Moreira AL, Velcheti V, Lau SCM, Sui P, Chen H, Diehl JA, Rustgi AK, Bass AJ, Poirier JT, Zhang X, Ji H, Zhang H, Wong KK. Pan Y, et al. Among authors: sherman f. Cancer Cell. 2023 Jan 9;41(1):88-105.e8. doi: 10.1016/j.ccell.2022.11.015. Epub 2022 Dec 15. Cancer Cell. 2023. PMID: 36525973 Free PMC article.
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy.
Mukhopadhyay S, Huang HY, Lin Z, Ranieri M, Li S, Sahu S, Liu Y, Ban Y, Guidry K, Hu H, Lopez A, Sherman F, Tan YJ, Lee YT, Armstrong AP, Dolgalev I, Sahu P, Zhang T, Lu W, Gray NS, Christensen JG, Tang TT, Velcheti V, Khodadadi-Jamayran A, Wong KK, Neel BG. Mukhopadhyay S, et al. Among authors: sherman f. Cancer Res. 2023 Dec 15;83(24):4095-4111. doi: 10.1158/0008-5472.CAN-23-2729. Cancer Res. 2023. PMID: 37729426
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer.
Tong X, Patel AS, Kim E, Li H, Chen Y, Li S, Liu S, Dilly J, Kapner KS, Zhang N, Xue Y, Hover L, Mukhopadhyay S, Sherman F, Myndzar K, Sahu P, Gao Y, Li F, Li F, Fang Z, Jin Y, Gao J, Shi M, Sinha S, Chen L, Chen Y, Kheoh T, Yang W, Yanai I, Moreira AL, Velcheti V, Neel BG, Hu L, Christensen JG, Olson P, Gao D, Zhang MQ, Aguirre AJ, Wong KK, Ji H. Tong X, et al. Among authors: sherman f. Cancer Cell. 2024 Mar 11;42(3):413-428.e7. doi: 10.1016/j.ccell.2024.01.012. Epub 2024 Feb 22. Cancer Cell. 2024. PMID: 38402609 Free article.
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLC.
Zhang H, Nabel CS, Li D, O'Connor RÍ, Crosby CR, Chang SM, Hao Y, Stanley R, Sahu S, Levin DS, Chen T, Tang S, Huang HY, Meynardie M, Stephens J, Sherman F, Chafitz A, Costelloe N, Rodrigues DA, Fogarty H, Kiernan MG, Cronin F, Papadopoulos E, Ploszaj M, Weerasekara V, Deng J, Kiely P, Bardeesy N, Vander Heiden MG, Chonghaile TN, Dowling CM, Wong KK. Zhang H, et al. Among authors: sherman f. J Thorac Oncol. 2023 Jul;18(7):882-895. doi: 10.1016/j.jtho.2023.03.014. Epub 2023 Mar 22. J Thorac Oncol. 2023. PMID: 36958689 Free article.
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression.
Okato A, Utsumi T, Ranieri M, Zheng X, Zhou M, Pereira LD, Chen T, Kita Y, Wu D, Hyun H, Lee H, Gdowski AS, Raupp JD, Clark-Garvey S, Manocha U, Chafitz A, Sherman F, Stephens J, Rose TL, Milowsky MI, Wobker SE, Serody JS, Damrauer JS, Wong KK, Kim WY. Okato A, et al. Among authors: sherman f. J Clin Invest. 2024 Jan 16;134(2):e169241. doi: 10.1172/JCI169241. J Clin Invest. 2024. PMID: 38226620 Free PMC article.
Polypill as geri-tonic.
Sherman FT. Sherman FT. Geriatrics. 2003 Aug;58(8):7-8. Geriatrics. 2003. PMID: 12938247 No abstract available.
The diversity of acetylated proteins.
Polevoda B, Sherman F. Polevoda B, et al. Among authors: sherman f. Genome Biol. 2002;3(5):reviews0006. doi: 10.1186/gb-2002-3-5-reviews0006. Epub 2002 Apr 30. Genome Biol. 2002. PMID: 12049668 Free PMC article. Review.
3'-end-forming signals of yeast mRNA.
Guo Z, Sherman F. Guo Z, et al. Among authors: sherman f. Trends Biochem Sci. 1996 Dec;21(12):477-81. doi: 10.1016/s0968-0004(96)10057-8. Trends Biochem Sci. 1996. PMID: 9009831 Free article. Review.
Nalpha -terminal acetylation of eukaryotic proteins.
Polevoda B, Sherman F. Polevoda B, et al. Among authors: sherman f. J Biol Chem. 2000 Nov 24;275(47):36479-82. doi: 10.1074/jbc.R000023200. J Biol Chem. 2000. PMID: 11013267 Free article. Review. No abstract available.
513 results